Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908(1):244–54.
Article CAS PubMed Google Scholar
Pawelec G, Larbi A, Derhovanessian E. Senescence of the human immune system. J Comp Pathol. 2010;142:39–S44.
Wikby A, Strindhall J, Johansson B. The immune risk profile and associated parameters in late life: lessons from the OCTO and NONA longitudinal studies. Handbook on Immunosenescence: Springer; 2009. pp. 3–28.
Chen X, Liu Q, Xiang AP. CD8 + CD28-T cells: not only age-related cells but a subset of regulatory T cells. Cell Mol Immunol. 2018;15(8):734–6.
Article CAS PubMed PubMed Central Google Scholar
Derhovanessian E, Maier AB, Beck R, Jahn G, Hähnel K, Slagboom PE, et al. Hallmark features of immunosenescence are absent in familial longevity. J Immunol. 2010;185(8):4618–24.
Article CAS PubMed Google Scholar
Xydonas S, Parissis J, Lioni L, Kapsimali V, Psarra E, Farmakis D, et al. Immunosenescence in patients with chronic systolic Heart Failure. J Cardiovasc Med. 2016;17(8):624–30.
Sainz T, Serrano-Villar S, Díaz L, Tomé MIG, Gurbindo MD, de José MI, et al. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults. Aids. 2013;27(9):1513–6.
Article CAS PubMed Google Scholar
Muller GC, Gottlieb MGV, Correa BL, Gomes Filho I, Moresco RN, Bauer ME. The inverted CD4: CD8 ratio is associated with gender-related changes in oxidative stress during aging. Cell Immunol. 2015;296(2):149–54.
Article CAS PubMed Google Scholar
Mou D, Espinosa J, Lo DJ, Kirk AD. CD28 negative T cells: is their loss our gain? Am J Transplant. 2014;14(11):2460–6.
Article CAS PubMed PubMed Central Google Scholar
Yadav AK, Banerjee D, Lal A, Jha V. Vitamin D deficiency, CD4 + CD28null cells and accelerated Atherosclerosis in chronic Kidney Disease. Nephrology. 2012;17(6):575–81.
Article CAS PubMed Google Scholar
Téo FH, de Oliveira RTD, Mamoni RL, Ferreira MCS, Nadruz W Jr, Coelho OR, et al. Characterization of CD4 + CD28null T cells in patients with coronary artery Disease and individuals with risk factors for Atherosclerosis. Cell Immunol. 2013;281(1):11–9.
Montoya-Ortiz G. Immunosenescence, aging, and systemic lupus erythematous. Autoimmune diseases. 2013;2013.
van den Laurens L, Patrick Sims G, van Adrianus Gijsbert J. Dorothea Elisabeth Fritsch-Stork R. Aging and systemic lupus erythematosus-immunosenescence and beyond. Curr Aging Sci. 2015;8(2):158–77.
Lang PO, Govind S, Aspinall R. Reversing T cell immunosenescence: why, who, and how. Age. 2013;35(3):609–20.
Koch S, Solana R, Rosa OD, Pawelec G. Human cytomegalovirus Infection and T cell immunosenescence: a mini review. Mech Ageing Dev. 2006;127(6):538–43.
Article CAS PubMed Google Scholar
Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A. Cytomegalovirus and human immunosenescence. Rev Med Virol. 2009;19(1):47–56.
Article CAS PubMed Google Scholar
Rasmussen LJH, Caspi A, Ambler A, Danese A, Elliott M, Eugen-Olsen J, et al. Association between elevated suPAR, a new biomarker of inflammation, and accelerated aging. The Journals of Gerontology: Series A. 2021;76(2):318–27.
Del Giudice M, Gangestad SW, Rethinking. IL-6 and CRP: why they are more than inflammatory biomarkers, and why it matters. Brain Behav Immun. 2018;70:61–75.
Zelová H, Hošek J. TNF-α signalling and inflammation: interactions between old acquaintances. Inflamm Res. 2013;62:641–51.
Kak G, Raza M, Tiwari BK. Interferon-gamma (IFN-γ): exploring its implications in infectious Diseases. Biomol Concepts. 2018;9(1):64–79.
Article CAS PubMed Google Scholar
Gaini S, Pedersen S, Koldkjær O, Pedersen C, Moestrup S, Møller H. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis. Clin Experimental Immunol. 2008;151(3):423–31.
Møller H, Aerts H, Grøbæk H, Peterslund N, Petersen PH, Hornung N, et al. Soluble CD163: a marker molecule for monocyte/macrophage activity in Disease. Scand J Clin Lab Investig. 2002;62(7):29–33.
Møller HJ. Soluble CD163. Scand J Clin Lab Investig. 2012;72(1):1–13.
Horn LA, Long TM, Atkinson R, Clements V, Ostrand-Rosenberg S. Soluble CD80 protein delays Tumor growth and promotes tumor-infiltrating lymphocytes. Cancer Immunol Res. 2018;6(1):59–68.
Article CAS PubMed Google Scholar
Kakoulidou M, Giscombe R, Zhao X, Lefvert A, Wang X. Human soluble CD80 is generated by alternative splicing, and recombinant soluble CD80 binds to CD28 and CD152 influencing T-cell activation. Scand J Immunol. 2007;66(5):529–37.
Article CAS PubMed Google Scholar
Xia F, Qian C-R, Xun Z, Hamon Y, Sartre A-M, Formisano A, et al. TCR and CD28 concomitant stimulation elicits a distinctive calcium response in naive T cells. Front Immunol. 2018;9:2864.
Article CAS PubMed PubMed Central Google Scholar
Costantini A, Viola N, Berretta A, Galeazzi R, Matacchione G, Sabbatinelli J, et al. Age-related M1/M2 phenotype changes in circulating monocytes from healthy/unhealthy individuals. Aging. 2018;10(6):1268.
Article CAS PubMed PubMed Central Google Scholar
Aiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino CM, et al. Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Front Immunol. 2019;10:2247.
Article CAS PubMed PubMed Central Google Scholar
Santoro A, Bientinesi E, Monti D. Immunosenescence and inflammaging in the aging process: age-related Diseases or longevity? Ageing Res Rev. 2021;71:101422.
Article CAS PubMed Google Scholar
Nielsen MC, Andersen MN, Rittig N, Rødgaard-Hansen S, Grønbæk H, Moestrup SK, et al. The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms. J Leukoc Biol. 2019;106(5):1129–38.
Article CAS PubMed Google Scholar
Sun Z, Yi L, Tao H, Huang J, Jin Z, Xiao Y, et al. Enhancement of soluble CD28 levels in the serum of Graves’ Disease. Central-European J Immunol. 2014;39(2):216.
Matsuyama Y, Asanuma K, Yoshida K, Hagi T, Iino T, Nakamura T, et al. The role of soluble CD80 in patients with soft tissue tumors. J Orthop Surg Res. 2022;17(1):1–9.
Khanolkar RC, Zhang C, Al-Fatyan F, Lawson L, Depasquale I, Meredith FM, et al. TGFβ2 induces the Soluble Isoform of CTLA-4–Implications for CTLA-4 based checkpoint inhibitor antibodies in malignant Melanoma. Front Immunol. 2022;12:5687.
Matsushita N, Kashiwagi M, Wait R, Nagayoshi R, Nakamura M, Matsuda T, et al. Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3. Clin Experimental Immunol. 2002;130(1):156–61.
Davis BH, Zarev PV. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Cytometry Part B: Clinical Cytometry: The Journal of the International Society for Analytical Cytology. 2005;63(1):16–22.
Onofre G, Kolácková M, Jankovicová K, Krejsek J. Scavenger receptor CD163 and its biological functions. Acta Medica (Hradec Kralove). 2009;52(2):57–61.
Article CAS PubMed Google Scholar
Etzerodt A, Moestrup SK. CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal. 2013;18(17):2352–63.
Article CAS PubMed PubMed Central Google Scholar
Weaver LK, Hintz-Goldstein KA, Pioli PA, Wardwell K, Qureshi N, Vogel SN, et al. Pivotal advance: activation of cell surface toll‐like receptors causes shedding of the hemoglobin scavenger receptor CD163. J Leukoc Biol. 2006;80(1):26–35.
Article CAS PubMed Google Scholar
Moreno JA, Ortega-Gomez A, Delbosc S, Beaufort N, Sorbets E, Louedec L, et al. In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis. Eur Heart J. 2012;33(2):252–63.
Article CAS PubMed Google Scholar
Nielsen MC, Andersen MN, Rittig N, Rødgaard-Hansen S, Grønbæk H, Moestrup SK, et al. The macrophage‐related biomarkers sCD163 and sCD206 are released by different shedding mechanisms. J Leukoc Biol. 2019;106(5):1129–38.
留言 (0)